Hiroki Shimizu

908 citations
74 papers · 667 indexed · h-index 17

Hiroki Shimizu

65 papers receiving 651 citations

Peers

Hiroki Shimizu
Comparison fields: 5 of 86
  • Immunology 131
  • Epidemiology 185
  • Critical Care and Intensive Care Medicine 27
  • Gastroenterology 28
  • Infectious Diseases 91
Replace Ann Elisabet Østvik with:
Ann Elisabet Østvik Norway
Marcus E. Martignoni Switzerland
Kiyoharu Fukushima Japan
Bridie J. Goggins Australia
B. Neumann Germany
Yasuhiko Fukuda Japan
A. BASHA United States
K. W. Annie Bang Canada
H J Hodgson United Kingdom
Hiroki Shimizu relative to Ann Elisabet Østvik Norway Ann Elisabet Østvik's profile →
Citations per field
00.5×2.6×
Ann Elisabet Østvik · 1×
Citations per year

Countries citing papers authored by Hiroki Shimizu

Since Specialization
Citations

This map shows the geographic impact of Hiroki Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Shimizu more than expected).

Fields of papers citing papers by Hiroki Shimizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Shimizu. The network helps show where Hiroki Shimizu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hiroki Shimizu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiroki Shimizu Line = papers co-authored together Hiroki Shimizu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20250
4 20240
5 20241
6 20243
7 20235
8 20230
9 20232
10 20223
11 20229
12 202210
13 20221
14 202118
15 202118
16 201616
17 20158
18 201126
19 201016
20
[Altered expression of Lewis antigens associated with malignant transformation in endometrial tissues].
19884

About Hiroki Shimizu

Hiroki Shimizu is a scholar working on Gastroenterology, Cancer Research and Immunology, having authored 74 papers that have together received 667 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (10 papers), MicroRNA in disease regulation (8 papers), Colorectal Cancer Surgical Treatments (7 papers), Galectins and Cancer Biology (7 papers), Esophageal Cancer Research and Treatment (6 papers), Circular RNAs in diseases (6 papers), Mycobacterium research and diagnosis (5 papers) and Gastrointestinal Tumor Research and Treatment (5 papers). The work is most often cited by research in Immunology (131 citations), Epidemiology (185 citations) and Critical Care and Intensive Care Medicine (27 citations). Hiroki Shimizu has collaborated with scholars based in Japan, Canada and United States. Frequent co-authors include Mikio Oka, Yasushi Obase, Yoshihiro Kobashi, Keita Kanki, Goshi Shiota, Keiji Mouri, Shigeki Katoh, Naoyuki Miyashita, Yoshihiro Ohue and Kazunobu Ouchi. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026